Table 1.
Prostate cancer patients | Control group | |
---|---|---|
Age (year) | ||
Range | 49–86 | 43–84 |
Mean ± SD | 71 ± 9 | 63 ± 9 |
Median | 71 | 63 |
| ||
PSAT (ng/mL) | ||
Range | 4.01–1489 | 0.004–3.94 |
Mean ± SD | 59.96 ± 182.67 | 1.09 ± 0.88 |
Median | 10.57 | 0.90 |
Prostate cancer patients | Control group | |
---|---|---|
Age (year) | ||
Range | 49–86 | 43–84 |
Mean ± SD | 71 ± 9 | 63 ± 9 |
Median | 71 | 63 |
| ||
PSAT (ng/mL) | ||
Range | 4.01–1489 | 0.004–3.94 |
Mean ± SD | 59.96 ± 182.67 | 1.09 ± 0.88 |
Median | 10.57 | 0.90 |